NCT07622940
- Conditions
- Adenocarcinoma Of Esophagus, Biomarker-selected CLDN18.2-positive and/or HER2-positive Disease, Disease Attributes, +4 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Recurrent or Metastatic Esophageal Adenocarcinoma
Explore clinical trials studying Recurrent or Metastatic Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study